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Neonatal screening for cystic fibrosis (CF) has been established in Leeds since 1975. The current method is measuring IRTand genotyping.
Newborn screening for CF results in a small but significant number of false positives. This study explored the psychosocial reactions to such
results in a group of parents (N=21) using semi-structured interviews. Responses were analysed using descriptive statistics and well-validated
content analysis.
Mothers described a range of emotions during the screening process including anxiety, distress and upset. Waiting for the repeat IRT test
results was identified as the most emotionally difficult stage. Discussion focuses on good practice and implications for CF services.
© 2006 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic fibrosis; Newborn screening; False positive; Psychosocial1. Introduction
Newborn screening programmes for cystic fibrosis (CF
NBS) have existed for more than 25 years. Each utilises the
assay of immunoreactive trypsinogen (IRT), in one or more
blood samples, the first usually being taken in the first week
of life. This is followed by, or in some instances occurs in
parallel with, analysis of common mutations of the cystic
fibrosis CF transmembrane conductance regulator (CFTR)
and sweat testing. There is now consistent evidence of the
benefits of, and minimal risk from, CF NBS programmes [1].
Clinical outcome studies have reported decreases in admis-
sions during first year of life [2] and early improved nutrition
for screened infants [3,4]. The most recent data supports the
introduction of CF NBS programmes, providing that early
diagnosis is followed up by high quality care in specialised
centres [5–7].⁎ Corresponding author. Regional Paediatric CF Unit, Children's Day
Hospital, St James's Hospital, Leeds LS9 7TF, UK. Tel.: +44 113 206 5897;
fax: +44 113 206 7011.
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doi:10.1016/j.jcf.2006.09.001There are short- and long-term psychosocial aspects of CF
NBS [8]. The waiting period between raised IRTon screening
and diagnostic confirmation is psychologically distressing for
parents and can cause depressive symptoms, mediated
amongst other things, by prior knowledge [9]. Short pre-
diagnosis periods are associatedwith less negative feelings and
increased confidence in doctors [10], with missed or late
diagnoses leading to anxiety, guilt and anger, and reduced trust
[11]. Following diagnosis on screening, families enter the
health care system with a range of psychosocial benefits [12].
With IRT alone, false-positive rates range from 0.3% to
0.6% [13], on which basis, frequency of occurrence will be
higher than eventual positive diagnoses. Such results have the
potential to cause increased parental anxiety, hypervigilance,
misconceptions about themeaning of test results, and lingering
concerns about the presence of CF even after the final
‘negative’ result [14]. Although early communication is
thought to have a seminal impact on how CF NBS psycho-
logically affects parents [15] and some tentative best-practice
recommendations being drawn [16], the emotional effects of
initial false-positive IRT results have received little empirical
attention.ed by Elsevier B.V. All rights reserved.
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IRTsample is sent for genotyping, searching for 32 mutations
and repeat IRT tests are organised before the genetics results
become available. Negative genotyping and a ‘normal’ repeat
IRT test are considered ‘unlikely to be CF’. All patients with
an initial positive IRTwent on to have a sweat test unless the
second IRT was negative and no mutations were identified.
On receipt of full ethical approval from the Leeds Teaching
Hospitals NHS Trust Ethics Committee, this study evaluated
the psychological impact of false-positive initial IRT tests on
parents whose child had been screened at birth.
2. Method
2.1. Participants
Participants were parents of newborns, born in Leeds
Teaching Hospitals, who received a false-positive initial IRT
test result between January 1998 and June 2002. Thirty-six
were contactable via telephone or post and were sent study
information packs together with invitations to participate.
Twenty-one mothers (58%), returned consent forms and
took part in a semi-structured interview. All were of Cau-
casian ethnic origin, with 20 (95%), being either married or
co-habiting. For 14 mothers (67%), this was their first or
only child. No participant had any other children receiving
raised IRT results and there was no family history of CF,
although 4 (19%), knew or had known someone with the
condition. Using the UK National Statistics Socio-economic
Classification System [17], which derives social class from
occupation, 5 participants were coded as Social Class II
(‘managerial and technical occupations’), 10 as Social Class
III (‘skilled occupations, non-manual’), and 1 as Social Class
IV (‘partly skilled occupations’). The remaining 6 partici-
pants could not be classed according to occupation, 4 being
full-time housewives, 1 a part-time college student and 1 for
whom the data was missing.
Twenty (95%) of the participants' children were born at
full-term. Seven (33%) were screened within the preceding
30 months, the remainder being screened between 2.5 to
5 years previously.
We believe the sample to be representative of parents who
have received a false-positive IRT result in our community
CF NBS.
2.2. Measures
The semi-structured interview was based on well-
established methods of interview format and question
construction [17]. It contained both open- and closed-ended
questions, generating qualitative and quantitative data.
Questions about psychological impact and service provision
focused on six separate time points; (i) initial ‘heel-prick’
blood-test, (ii) reporting of initial raised IRT result, (iii) repeat
IRT test, (iv) awaiting repeat IRT test results, (v) receiving
repeat IRT test result, (vi) residual effects. Psychologicalquestions focused on reactions and coping mechanisms.
Service-related questions pertained to the experiences of
undergoing IRT tests, time-scales, the feedback process and
the role of the health professionals involved. Examples of
interview questions are contained in Appendix 1.
2.3. Procedure
Participants were interviewed at home by one of two
interviewers (JM, KQ), who were independent of the
screening programme. Interviews lasted between 30 and
40 min. Responses were transcribed verbatim, with tran-
scriptions being anonymised for analysis.
2.4. Analysis
Transcripts were subjected to Content Analysis (CA),
responses were coded according to a coding frame developed
following recommended procedures [18,19]. Response
categories, consistent with recommended CA procedures
[19], were created to be exhaustive and ‘mutually exclusive’.
Coding and category identification were undertaken by the
two lead researchers and all coding cross-checked before
15% were inter-rated by a third independent researcher with
82% agreement. Closed-ended questions generated categor-
ical data, yielding descriptive statistics.
3. Results
The results are summarised in Table 1 which shows
themes and results of analysis at the 6 different stages of the
screening process. Areas of current good practice and iden-
tified suggestions for improved practice are also presented.
4. Discussion
Although all screening programmes carry risk of false-
positive results, the risk is higher in CF NBS. Parents in this
study described wide-ranging and often strong, emotional
reactions to receiving such a result and stated the importance
of accurate and empathic communication and consistent
information-giving in order to minimise psychological dis-
tress; findings which echo previous hypotheses [20–22].
Improvements for the management of the early stages of
the screening process are indicated, particularly as variability
was reported in how health visitors communicated initial
raised IRT results. This seemed a particular difficulty when
the health visitor was unable to provide adequate information
about the screening process or contain parents' anxieties.
This was in contrast to the experience of parents who
received repeat test results by CF nurse specialist (CFNS),
who reported benefiting from the CFNSs' knowledgeable
understanding approach, which could be adapted to their
needs. Health visitors may require guidance on CF screening
and false-positive IRT results and support in communicating
raised IRT results to parents.
Table 1
Themes and results of analysis, good practice and suggestions for improved practice
Stage of testing Themes and results of analysis Identified current good practice Identified suggestions for improved
practice
Initial heel-prick
test
▪ Majority reported ‘feeling ok’ about heel-prick
test and viewed it as ‘routine and necessary’.
▪ Initial test performed at home
or in hospital soon after birth.
▪ Review information provided about
CF newborn screening and parental
consent.
▪ 57% aware child would be tested for CF
immediately after birth.
▪ Provide parents with written
information re: possibility of receiving
false-positive result and feedback
procedure for heel-prick test results.
Feedback of initial
raised IRT
result
▪ 86% were informed of result by Health
Visitor (HV).
▪ HV informs parents of initial
raised IRT result in person.
▪ Develop protocol for HVs to follow
in the case of initial raised results.
Develop written guidelines and
consider workshops for HVs on CF
screening and re-test procedure.
▪ 71% reported HV was appropriate
person to feedback.
▪ HV advises parents about
possibility of false positives.
▪ HV informs parents about possibility
of false positives without exception.
▪ 57% reported having enough information,
however amount and content were limited.
▪ 2 most frequently reported categories of
feelings: ‘worried/concerned/nervous/upset’;
‘devastated/distraught/hysterical’.
Repeat IRT test ▪ CF nurse performed repeat test. ▪ CF nurse performs repeat test at
home and provides information.
▪ CF nurse gives parents written
information about waiting time for
repeat results, procedure for being
informed etc.
▪ 58% had repeat test the same or next day.
None waiting over 5 days.
▪ Information given includes
explanation of possibility of
false positives.
▪ Weekends and bank holidays taken
into account when estimating waiting
time for repeat result.
▪ 90% reported being given enough information,
varied on individual need.
▪ Adequate amount of
information based on individual need.
▪ Consider limiting amount of
information given relating to signs
and symptoms of CF in view of
parents' hypervigilance to ‘signs and
symptoms’ during wait for repeat test
results.
▪ 95% reported being informed verbally of length
of wait for repeat test results.
▪ CF nurse available/contact
number given.
▪ Majority listed helpful attributes of CF nurse.
53% mentioned ‘knowledgeable’ and ‘giving an
explanation’ as important. Other attributes
included ‘professional/competent/efficient’ and
‘friendly/helpful/understanding’.
▪ Mixed emotions were reported. 2 most frequent
categories reported: ‘nervous/anxious/worried/
concerned’; ‘glad it was being done’.
▪ Main coping strategy ‘trying to carry on as normal’.
Waiting for repeat
IRT results
▪ Waiting reported to be the most difficult time. ▪ Reduce waiting time for repeat test
results. Review current procedures.
▪ 62% reported length of wait was ‘not ok’ and
suggested service improvement to reduce wait.
▪ Regular audit of waiting times to
identify potential problems and
service improvements.
▪ Wide range of emotions reported (largely negative).
Over 50% reported 4–5 different emotions.
‘Upset/crying’ reported by 50%. Others included
‘optimistic’, ‘guilty’, ‘nervous/anxious’.
▪ Main coping strategies: ‘trying to carry on as
normal but having difficulty doing so’;
‘thoughts of future with CF’.
▪ Most reported hypervigilance for signs/symptoms
of CF in their child.
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Table 1 (continued )
Stage of testing Themes and results of analysis Identified current good practice Identified suggestions for improved
practice
Receiving repeat
IRT test results
▪ Over 80% reported ‘relief/weight lifted’. 2 reported
frustrations for what they had been through and
thoughts of other families receiving the diagnosis.
▪ CF nurse informs of final
all clear result by telephone.
▪ All happy to receive result by telephone. ▪ Routine follow-up from CF
nurse not necessary. Availability
of CF nurse and
contact number sufficient.
Residual effects ▪ Majority reported relief and getting on with
things in the immediate following weeks.
▪ No significant evidence of long
lasting emotional effects/harm
to families.
▪ Unit to implement suggested
improvements to service to reduce
risk of short term and residual
emotional effects.
▪ Parents did not feel need for further ongoing support.
▪ 43% reported recalling the process as a ‘memory of a
difficult time’. 24% reported ‘upset/sadness’, 14%
reported residual anger at the way that they were
informed of the raised result.
▪ Participants were in favour of newborn
screening for CF.
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most difficult time for parents. Reducing this delay, or not
being told of the result before a more definitive diagnosis
could be given, was stated by many participants as a
significant service improvement. Consistent with previous
research, receiving an initial raised screening test result was
associated with increased anxiety and hypervigilance in
parents [14]. Although participants recalled the screening
process as a difficult emotional experience, there were no
reports of longer-term psychological effects. This would
seem an important area for further investigation. Several
research questions remain. What impact does ‘length wait for
second IRT’ have on outcomes? Even although there is a
final negative result, do parents become hypervigilant about
their child's health? We believe that our methods would be
appropriate in attempting to answer such questions.
However, future projects would need to thoroughly consider
the ethics of such a study and the potential for raising
psychological distress in parents who may have successfully
adapted to the false-positive result, or who have forgotten it.
Cumulative world-wide experience of neonatal screening
for CF seems to be ‘tipping the balance of opinion’ towards
initiating programmes where none exist [1,5,6,7,20]. As a
consequence, newborn screening protocols for CF are being
introduced throughout the world. Most protocols include an
initial IRT test and then some combination of mutation
analysis and repeat IRT testing to reduce the number of false-
positive results [23]. Sweat tests are still recommended to
confirm the diagnosis even in patients with two identified CF
causing mutations. There are technical difficulties in per-
forming sweat tests in babies, there was a 53% failure rate in
newborns using the nanoduct method [24], a 20% failure rate
using the macroduct method and a 10% failure rate using the
Gibson Cooke technique in children less than 6 weeks [25].
However, even during a short interim period between araised IRT result and diagnosis, it is unrealistic to expect
parents not to seek out information on the Internet, which at
times can be unreliable. Written information needs to be
given to parents that focuses on screening itself, balancing
this with information about CF.
It is acknowledged that the small sample size in this study
may limit the representativeness of the sample and generali-
sability of the findings. Studies using this type of retrospec-
tive qualitative methodology are also predisposed to recall
bias. However, our findings show that, despite often re-
calling the experience of receiving a false-positive IRT result
as difficult, parents support such initiatives. They identified
several areas for service development and gave examples of
good current practice. To summarise, these are:
• Providing information for parents about CF screening and
risk of false positives
• Guidelines and support for health visitors in communi-
cating with parents about initial raised IRT results
• Providing clear, accurate, but limited information about
CF at early stages
• Reducing waiting times for repeat test results
Future research directions need to focus on (i) exploring
longer-term psychological outcomes for parents of screened
infants, (ii) the psychosocial consequences of infants iden-
tified as having ‘carrier’ status, (iii) education programmes
for primary health carers and (iv) evaluation of support for
parents.
Appendix A. Example of questions relating to ‘receiving
initial raised result’
How soon after the birth of your infant were you notified
of the initial raised test result?
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What did they advise you to do?
Do you think that was the best person to tell you? (If ‘No’,
who would you like to have told you?)
Was enough information available to you at this time? (If
‘No’, what type of information would you have liked?)
Who did you tell about the raised test result?
Who did you have around at this time for support?
How did you feel about this result?
How did you cope with hearing about the raised result?
(What did you do?)
How would you describe your mood at this time?
What was helpful about the way the raised result was
given to you?
What could have been done better?
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